Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Melanotan IIUnderstand the science

How Oral Pigmentation Changed Over Three Months

3 numbered sourcesSource years 2025, 2026

Peptides are short chains of amino acids linked by peptide bonds. Some change how cells make pigment. Melanotan II mimics part of a natural melanocortin signal that can stimulate pigment-producing cells. In 2026, dentist Alexander Bonchev reported how the color of one patient's gums and inner cheeks changed during reported Melanotan II exposure and over three months of follow-up. [1]

The patient already had some brown coloration on the lower gums in photographs from two years before the reported exposure. The later examination showed darker, more extensive pigmentation across the gums and additional flat patches on both inner cheeks. The tongue and palate were unaffected. The earlier photographs let the author distinguish changes in previously pigmented tissue from changes at sites where pigmentation had not been documented before. [1]

About four weeks after the patient stopped using the product, the color and area of the cheek patches had decreased. The gum changes persisted at that visit. At three months, gum pigmentation had faded but had not returned to its earlier appearance. Some of the cheek patches had cleared, while others remained lighter. The two sites followed different courses in this one patient. The photographs and timeline cannot tell readers how often this happens or how long pigmentation usually lasts. [1]

A separate case published in 2025 described an oral mass that a biopsy identified as melanoma after reported exposure to a product described as Melanotan II. That case documented a different clinical finding in a different person. The reports do not demonstrate a progression from the flat pigmentation in Bonchev's patient to cancer, or establish what caused the tumor in the earlier case. [1, 2]

A different question is now registered for research in people with stable nonsegmental vitiligo, a condition that causes patches of skin to lose pigment. The 2026 registry entry describes a randomized trial of Melanotan II or placebo alongside the same light therapy in both groups, with change in a skin pigmentation score measured at 24 weeks. The registry had no results posted. That planned comparison concerns skin repigmentation and cannot be used to predict changes inside the mouth. [3]

Sources

Original works cited in this article. Links open the external record in a new tab.

Shop Melanotan II

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Also available as Markdown or JSON.